Acadia Healthcare (NASDAQ:ACHC) Given New $37.00 Price Target at Mizuho

Acadia Healthcare (NASDAQ:ACHC) had its target price trimmed by Mizuho from $48.00 to $37.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The firm currently has a neutral rating on the stock.

ACHC has been the topic of a number of other research reports. Cantor Fitzgerald reiterated a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a research report on Tuesday, December 10th. TD Cowen reduced their price objective on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Bank of America cut their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a report on Friday, February 28th. KeyCorp decreased their price target on shares of Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a research note on Monday, March 3rd. Finally, StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, Acadia Healthcare presently has an average rating of “Hold” and a consensus price target of $52.19.

Acadia Healthcare Stock Down 0.4 %

Shares of NASDAQ ACHC opened at $28.81 on Tuesday. The business has a 50-day moving average of $37.92 and a two-hundred day moving average of $45.82. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The company has a market capitalization of $2.68 billion, a price-to-earnings ratio of 9.45, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. Acadia Healthcare has a 1 year low of $27.61 and a 1 year high of $82.41.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of ACHC. Lindbrook Capital LLC boosted its position in shares of Acadia Healthcare by 1,342.0% during the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock worth $29,000 after purchasing an additional 671 shares in the last quarter. Blue Trust Inc. boosted its stake in shares of Acadia Healthcare by 69.4% during the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after acquiring an additional 345 shares in the last quarter. Nisa Investment Advisors LLC grew its holdings in shares of Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after acquiring an additional 301 shares during the period. Signaturefd LLC grew its holdings in shares of Acadia Healthcare by 460.6% in the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock worth $48,000 after acquiring an additional 1,004 shares during the period. Finally, Fifth Third Bancorp increased its stake in Acadia Healthcare by 56.0% in the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock valued at $50,000 after purchasing an additional 454 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.